Cart
sales@molnova.com
Deacylketoconazole
CAS No. 67914-61-8
Deacylketoconazole ( Deacyl ketoconazole )
Catalog No. M27360 CAS No. 67914-61-8
Deacylketoconazole is a Ketoconazole derivative and is also an antifungal agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 113 | In Stock |
|
| 50MG | 161 | In Stock |
|
| 100MG | 231 | In Stock |
|
| 200MG | 385 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDeacylketoconazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionDeacylketoconazole is a Ketoconazole derivative and is also an antifungal agent.
-
DescriptionDeacylketoconazole is a Ketoconazole derivative and is also an antifungal agent. Deacylketoconazole was 15- to 50-fold more active against Plasmodium falciparum than was ketoconazole.
-
SynonymsDeacyl ketoconazole
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorSETDB1-TTD
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67914-61-8
-
Formula Weight489.4
-
Molecular FormulaC24H26Cl2N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1ccc(c(Cl)c1)[C@]1(Cn2ccnc2)OC[C@@H](COc2ccc(cc2)N2CCNCC2)O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guo Y, et, al. Structure-Guided Discovery of a Potent and Selective Cell-Active Inhibitor of SETDB1 Tudor Domain. Angew Chem Int Ed Engl. 2021 Apr 12;60(16):8760-8765.
molnova catalog
related products
-
Lysozyme from chicke...
Lysozyme from chicken egg white is a bactericidal enzyme present in chicken eggs, and it lyses gram-positive bacteria.
-
Irloxacin
Irloxacin is a new quinolone derivative, and shows greater activity with an acid pH. Irloxacin has a good in vitro antimicrobial spectrum against both gram-positive and gram-negative bacteria.
-
QcrB inhibitor TB47
QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M.
